Ankara University Faculty of Medicine Department of Pediatric Hematology and BMT Unit Ankara Türkiye

Bristol Royal Hospital for Children Dept of Paediatric Oncology BMT Bristol

Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases Dept for Pediatric Hematology and Hemopoietic Stem Cell Transplantation Budapest Hungary

CHU Bordeaux Groupe Hospitalier Pellegrin Enfants Onco Hématologie Pédiatrique

Copenhagen University Hospital Rigshospitalet Department of Paediatric and Adolescent Medicine Copenhagen Denmark

Department of Pediatric Hematology and Oncology IRRCS Ospedale Pediatrico Bambino Gesù Catholic University of the Sacred Heart Rome

Department of Pediatric Hematology Oncology and BMT Wroclaw Medical University Wroclaw

Department of Pediatric Hematology Oncology and Stem Cell Transplantation University of Regensburg Regensburg

Division of Pediatric Stem Cell Therapy Department of Pediatric Oncology Hematology and Clinical Immunology Medical Faculty Heinrich Heine University Düsseldorf

EBMT Paris Study Unit Sorbonne University Saint Antoine Hospital AP HP INSERM UMRs 938 Paris

EBMT Statistical Unit Sorbonne University Saint Antoine Hospital AP HP INSERM UMRs 938 Paris

Fondazione IRCCS San Gerardo dei Tintori Pediatric Stem Cell Transplant Unit Monza Italy; University of Milano Bicocca Department of Medicine and Surgery Milano

Hopital de la Timone Département Hématologie Oncologie Pédiatrique Marseille

Hospital for Children and Adolescents Helsinki University Hospital and Helsinki University Helsinki

Institut d`Hematologie et d`Oncologie Pediatrique Unité de coordination interne et externe Lyon

Oslo University Hospital Rikshospitalet Clinic for Cancer Medicine Hematology Dept Olso

Pediatric Hematology and Immunology Department Robert Debre Hospital GHU APHP Nord Université Paris Cité Paris

Pediatric Hematology Oncology Unit Department of Mother and Child Azienda Ospedaliera Universitaria Integrata Verona

Pediatric Onco Hematology Stem Cell Transplantation and Cell Therapy Division Regina Margherita Children's Hospital University of Turin Turin

Princess Maxima Center University Hospital for Children Stem cell transplantation Utrecht Netherlands

Royal Manchester Children's Hospital Department of Paediatric Haematology Bone Marrow Unit Manchester

Service Onco Hématologie Pédiatrique Hôpital Mère Enfant Nantes University Hospital Nantes

St Anna Kinderspital Stem Cell Transplantation Unit Vienna

University Hospital Collegium Medicum UMK Department of Pediatric Hematology and Oncology Bydgoszcz

University Hospital Motol Department of Paediatric Haematology And Oncology Prague Czech Republic

Willem Alexander Children's Hospital Pediatric Stem Cell Transplantation Program Leiden University Hospital Leiden

Zobrazit více v PubMed

Ljungman P, Brand R, Hoek J, et al. . Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation. Clin Infect Dis. 2014;59(4):473-481. PubMed

Boeckh M, Nichols WG. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood. 2004;103(6):2003-2008. PubMed

Green ML, Leisenring W, Xie H, et al. . Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study. Lancet Haematol. 2016;3(3):e119-127. PubMed PMC

Teira P, Battiwalla M, Ramanathan M, et al. . Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis. Blood. 2016;127(20):2427-2438. PubMed PMC

Ljungman P, Brand R, Einsele H, Frassoni F, Niederwiesser D, Cordonnier C. Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis. Blood. 2003;102(13):4255-4260. PubMed

Schmidt-Hieber M, Labopin M, Beelen D, et al. . CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT. Blood. 2013;122(19):3359-3364. PubMed

Broers AE, van Der Holt R, van Esser JW, et al. . Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood. 2000;95(7):2240-2245. PubMed

Kollman C, Spellman SR, Zhang MJ, et al. . The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. Blood. 2016;127(2):260-267. PubMed PMC

Armand P, Kim HT, Zhang MJ, et al. . Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study. Biol Blood Marrow Transplant. 2012;18(2):280-288. PubMed PMC

Dohner H, Estey E, Grimwade D, et al. . Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424-447. PubMed PMC

Lugthart G, van Ostaijen-Ten Dam MM, Jol-van der Zijde CM, et al. . Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20(5):655-661. PubMed

Portillo V, Masouridi-Levrat S, Royston L, et al. . Revisiting cytomegalovirus serology in allogeneic hematopoietic cell transplant recipients. Clin Infect Dis. 2024;78(2):423-429. PubMed PMC

Valle-Arroyo J, Paez-Vega A, Fernandez-Moreno R, et al. . Humoral/cellular immune discordance in stem cell donors: impact on cytomegalovirus-specific immune reconstitution after related hematopoietic transplantation. Transplant Cell Ther. 2022;28(10):703.e1-703.e8. PubMed